| Autor: |
Marin-Oto, Marta, Sanz-Rubio, David, Santamaría-Martos, Fernando, Benitez, Ivan, Simon, Ana L., Forner, Marta, Cubero, Pablo, Gil, Ana, Sanchez-de-laTorre, Manuel, Barbe, Ferran, Marin, José M. |
| Rok vydání: |
2022 |
| Předmět: |
|
| DOI: |
10.6084/m9.figshare.20115720.v1 |
| Popis: |
Additional file 1. Additional methods, figures, tables. Table S1. Inclusion and exclusion criteria. Table S2. Univariate association of sRAGE (log10) with clinical characteristics in healthy subjects, nonsmokers, and smokers (n = 141). Table S3. Multivariate association of sRAGE (log10) with clinical characteristics in patients with only OSA (n = 79). Table S4. Multivariate association of sRAGE (log10) with clinical characteristics in patients with COPD (n = 62). Table S5. Multivariate association of sRAGE (log10) with clinical characteristics in patients with OSA-COPD overlap (n = 35). Table S6. Median and interquartile range of sRAGE values at baseline and at 1-year follow-up according with studied groups. Figure S1. Soluble receptor for advanced glycation end-products (sRAGE) values. Median and corresponding interquartile range for each diagnostic group separated based on smoking status at baseline. HS: healthy smokers; OSA: obstructive sleep apnoea; COPD: chronic obstructive pulmonary disease. Figure S2. Individual changes in sRAGE among healthy nonsmokers, smokers and patients with COPD from baseline to one-year follow-up. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
